Ads
related to: genetics
Search results
PolygenRx Wants to Use Genetics to Guide Chronic Disease Treatments, Starting With Hypertension
GenomeWeb News· 13 hours agoGenetics, often typecast as the future of medicine for rare and monogenic conditions, could also be...
Myriad Genetics director Lee Nisley sells $156,860 in company stock By Investing.com
Investing.com· 6 days agoFollowing the sale, Nisley still retains a significant stake in the company, owning 66,650 shares of...
Atossa Genetics Inc. (ATOS) is a Great Momentum Stock: Should You Buy?
Zacks via Yahoo Finance· 1 day agoBelow, we take a look at Atossa Genetics Inc. (ATOS), which currently has a Momentum Style Score of...
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer
WKBN 27 Youngstown· 2 days agoSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live ...
Genetics reveals surprising origin of the German cockroach
Cosmos· 23 hours agoThe German cockroach lurks in human homes, cities, and structures worldwide. The pest species,...
How cockroaches spread across the world to become the survival experts we know today
Fox News· 13 hours agoCockroaches are experts at surviving indoors, hiding in kitchen pipes or musty drawers. A new study...
Myriad Genetics CEO Paul J. Diaz sells shares worth over $5.7 million By Investing.com
Investing.com· 6 days agoPaul J. Diaz, the President and CEO of Myriad Genetics Inc. (NASDAQ:MYGN), has recently sold a...
Employee Mobility and Trade Secrets in the Golden Era of Life Sciences Innovation | JD Supra
JD Supra· 20 hours ago—including genetics, immunology, cell biology, and artificial intelligence—changing the speed, efficiency, and cost at which innovation occurs. With this era has come a fierce ...
Amalgamated Bank Buys 692 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
ETF DAILY NEWS· 4 days agoAmalgamated Bank lifted its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with ...
Insider Sale: President and CEO Paul Diaz Sells 227,844 Shares of Myriad Genetics Inc (MYGN)
GuruFocus.com via Yahoo Finance· 6 days agoOn May 15, 2024, Paul Diaz, President and Chief Executive Officer of Myriad Genetics Inc...